110 related articles for article (PubMed ID: 24333154)
1. Model for tumour growth with treatment by continuous and pulsed chemotherapy.
Borges FS; Iarosz KC; Ren HP; Batista AM; Baptista MS; Viana RL; Lopes SR; Grebogi C
Biosystems; 2014 Feb; 116():43-8. PubMed ID: 24333154
[TBL] [Abstract][Full Text] [Related]
2. Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model.
Iliadis A; Barbolosi D
Comput Biomed Res; 2000 Jun; 33(3):211-26. PubMed ID: 10860586
[TBL] [Abstract][Full Text] [Related]
3. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
Boldrini JL; Costa MI
IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
[TBL] [Abstract][Full Text] [Related]
4. Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response.
Rodrigues DS; de Arruda Mancera PF
Math Biosci Eng; 2013 Feb; 10(1):221-34. PubMed ID: 23311370
[TBL] [Abstract][Full Text] [Related]
5. [Dosage regimen optimization in cancer chemotherapy using a mathematical model].
Barbolosi D; Freyer G; Ciccolini J; Iliadis A
Bull Cancer; 2003 Feb; 90(2):167-75. PubMed ID: 12660135
[TBL] [Abstract][Full Text] [Related]
6. [Kinetics of breast neoplasms].
Surbone A; Norton L
Minerva Med; 1994; 85(1-2):7-16. PubMed ID: 8152580
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy may be delivered based on an integrated view of tumour dynamics.
Ribba B; You B; Tod M; Girard P; Tranchand B; Trillet-Lenoir V; Freyer G
IET Syst Biol; 2009 May; 3(3):180-90. PubMed ID: 19449978
[TBL] [Abstract][Full Text] [Related]
8. A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy.
López AG; Seoane JM; Sanjuán MA
Bull Math Biol; 2014 Nov; 76(11):2884-906. PubMed ID: 25348062
[TBL] [Abstract][Full Text] [Related]
9. Gompertz model with delays and treatment: mathematical analysis.
Bodnar M; Piotrowska MJ; Foryś U
Math Biosci Eng; 2013 Jun; 10(3):551-63. PubMed ID: 23906135
[TBL] [Abstract][Full Text] [Related]
10. Optimal chemotherapy regimens: influence of tumours on normal cells and several toxicity constraints.
Matveev AS; Savkin AV
IMA J Math Appl Med Biol; 2001 Mar; 18(1):25-40. PubMed ID: 11339336
[TBL] [Abstract][Full Text] [Related]
11. Drug scheduling of cancer chemotherapy based on natural actor-critic approach.
Ahn I; Park J
Biosystems; 2011 Nov; 106(2-3):121-9. PubMed ID: 21839140
[TBL] [Abstract][Full Text] [Related]
12. Mathematical and numerical analysis for a model of growing metastatic tumors.
Barbolosi D; Benabdallah A; Hubert F; Verga F
Math Biosci; 2009 Mar; 218(1):1-14. PubMed ID: 19121638
[TBL] [Abstract][Full Text] [Related]
13. A mathematical model of the development of drug resistance to cancer chemotherapy.
Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular "pruning".
d'Onofrio A; Gandolfi A
J Theor Biol; 2010 May; 264(2):253-65. PubMed ID: 20100496
[TBL] [Abstract][Full Text] [Related]
15. Mathematical modelling for the assessment of the effect of drug application delays in metronomic chemotherapy of cancer due to physiological constraints.
Mukherjee A; Majumder D
Biosystems; 2008 Jan; 91(1):108-16. PubMed ID: 17889991
[TBL] [Abstract][Full Text] [Related]
16. Modelling and simulation of chemotherapy of haematological and gynaecological cancers.
Nani FK; Oğuztöreli MN
IMA J Math Appl Med Biol; 1999 Mar; 16(1):39-91. PubMed ID: 10335600
[TBL] [Abstract][Full Text] [Related]
17. Regression and regrowth of tumour cords following single-dose anticancer treatment.
Bertuzzi A; D'Onofrio A; Fasano A; Gandolfi A
Bull Math Biol; 2003 Sep; 65(5):903-31. PubMed ID: 12909255
[TBL] [Abstract][Full Text] [Related]
18. Investigation of various growth mechanisms of solid tumour growth within the linear-quadratic model for radiotherapy.
McAneney H; O'Rourke SF
Phys Med Biol; 2007 Feb; 52(4):1039-54. PubMed ID: 17264369
[TBL] [Abstract][Full Text] [Related]
19. Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model.
Chen JH; Kuo YH; Luh HP
Math Biosci; 2013 Oct; 245(2):282-98. PubMed ID: 23927854
[TBL] [Abstract][Full Text] [Related]
20. A novel method for assessing in vitro oncology drug combinations using growth rates.
Pashkevich M; Iversen P; Brooks H
J Biopharm Stat; 2012; 22(3):496-518. PubMed ID: 22416837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
